Research Fellow post available to join my team, pre-clinical gene therapy project 🧬🧠 applyhttps://www.ucl.ac.uk/work-at-ucl/search-ucl-jobs/details?nPostingId=5896&nPostingTargetId=12733&id=Q1KFK026203F3VBQBLO8M8M07&LG=UK&languageSelect=UK&mask=ext
@UCL_IfWH@_BSGCT@UCLTRO
Our £40m #Funding call to create Translational #RareDisease Centres is LIVE! 🙌
With treatments only available for a small number of rare diseases, we hope to drive the progression of lab-based ideas into medical breakthroughs for #Patients🤝
Apply now➡️ bit.ly/3oCPzrf
🧵
And don't forget to join our session on the “Approaches to Market for #Medicines Repurposing” educational series to guide academic researchers through the repurposing journey.
Sign up to @RareBeacon’s repurposing seminars to find out more➡️bit.ly/3mf9dZj
New year new goals! Do not miss the Therapeutic Acceleration Support (TAS) Fund – LifeArc Rare Diseases Funding Call, closing on Wed 11 January 2023 (5 pm).
📢£4.25m #ResearchGrant awarded to kick start collaborative efforts to end #MND. LifeArc, alongside charities, patients, researchers & government research orgs, will support #medicalrearch at 6 UK unis to discover MND treatments.
➡️bit.ly/3zQMY0m#MNDAwarenessDay
Here, we discuss viral, gene editing and non-viral therapeutic strategies in the context of #DravetSyndrome and summarise the pre-clinical development of each 👇
This will be an awesome talk!! Simon is a brilliant public speaker and his talk is sure to be interspersed with film related analogies! This is one not to be missed!
Hi @JDSports I placed an order and paid for next day delivery with DPD. Only 1 item out of a large delivery was delivered - the rest is apparently with Hermes and “delayed”. I paid extra specifically to avoid Hermes. What is going on please?
Sponsored by Boots, our Business award goes to a company leading the charge on a reproductive revolution, making information about female health accessible and affordable. The Women of 2021 in Business goes to the founders of @hertilityhealth#WOTYA21